Exact Mass: 786.2570662
Exact Mass Matches: 786.2570662
Found 124 metabolites which its exact mass value is equals to given mass value 786.2570662,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Purpureaside
Purpureaside C is an oligosaccharide. Purpureaside C is a natural product found in Cistanche salsa, Digitalis purpurea, and Rehmannia glutinosa with data available.
echinacoside
Echinacoside, one of the phenylethanoids isolated from the stems of Cistanche deserticola, effectively inhibits Wnt/β-catenin signaling. Echinacoside elicits neuroprotection by activating Trk receptors and their downstream signal pathways. Antiosteoporotic activity[1][2][3]. Echinacoside, one of the phenylethanoids isolated from the stems of Cistanche deserticola, effectively inhibits Wnt/β-catenin signaling. Echinacoside elicits neuroprotection by activating Trk receptors and their downstream signal pathways. Antiosteoporotic activity[1][2][3].
Estradiol mustard
D000970 - Antineoplastic Agents > D018906 - Antineoplastic Agents, Alkylating > D009588 - Nitrogen Mustard Compounds C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
Isorhamnetin 3-O-[b-D-glucopyranosyl-(1->2)-[a-L-rhamnopyranosyl-(1->6)]-b-D-glucopyranoside]
Isorhamnetin 3-O-[b-D-glucopyranosyl-(1->2)-[a-L-rhamnopyranosyl-(1->6)]-b-D-glucopyranoside] is found in nuts. Isorhamnetin 3-O-[b-D-glucopyranosyl-(1->2)-[a-L-rhamnopyranosyl-(1->6)]-b-D-glucopyranoside] is a constituent of peanut skins (Arachis hypogaea). Constituent of peanut skins (Arachis hypogaea). Isorhamnetin 3-O-[b-D-glucopyranosyl-(1->2)-[a-L-rhamnopyranosyl-(1->6)]-b-D-glucopyranoside] is found in nuts.
Hydroxypropionic porphyrin III
Hydroxypropionic porphyrin III is a porphyrin isolated only in patients with porphyria cutanea tarda. Porphyria cutanea tarda (PCT) is a metabolic disorder of haeme biosynthesis caused by decreased activity of uroporphyrinogen decarboxylase. Porphyria cutanea tarda is manifest by fragility, erosions, bullae, milia and scars on sun-exposed skin. Excess porphyrins in the skin interact with light of approximately 400 nm-wavelength radiant energy, forming reactive oxygen species. Porphyria cutanea tarda is categorized as familial, acquired or toxic. Factors that may induce clinical expression of PCT in susceptible individuals include alcohol, oestrogen, iron, polyhalogenated compounds and viral infections. Porphyria cutanea tarda is associated with an increased incidence of the haemochromatosis gene. Treatments for PCT include withdrawal of aggravating factors, phlebotomy and oral antimalarial medications. Porphyria cutanea tarda is associated with hepatic iron overload and responds to iron-reduction therapy. Porphyria cutanea tarda is the most common porphyria, followed by acute intermittent porphyria and erythropoietic protoporphyria. The molecular genetics of the porphyrias is very heterogenous. (PMID: 16315139, 7655298, 11105361) [HMDB] Hydroxypropionic porphyrin III is a porphyrin isolated only in patients with porphyria cutanea tarda. Porphyria cutanea tarda (PCT) is a metabolic disorder of haeme biosynthesis caused by decreased activity of uroporphyrinogen decarboxylase. Porphyria cutanea tarda is manifest by fragility, erosions, bullae, milia and scars on sun-exposed skin. Excess porphyrins in the skin interact with light of approximately 400 nm-wavelength radiant energy, forming reactive oxygen species. Porphyria cutanea tarda is categorized as familial, acquired or toxic. Factors that may induce clinical expression of PCT in susceptible individuals include alcohol, oestrogen, iron, polyhalogenated compounds and viral infections. Porphyria cutanea tarda is associated with an increased incidence of the haemochromatosis gene. Treatments for PCT include withdrawal of aggravating factors, phlebotomy and oral antimalarial medications. Porphyria cutanea tarda is associated with hepatic iron overload and responds to iron-reduction therapy. Porphyria cutanea tarda is the most common porphyria, followed by acute intermittent porphyria and erythropoietic protoporphyria. The molecular genetics of the porphyrias is very heterogenous. (PMID: 16315139, 7655298, 11105361).
Heptacarboxylporphyrin I
Heptacarboxylporphyrin I is a bile product that arises from the conversion of Heptacarboxylporphyrinogen I to Heptacarboxylporphyrin I by porphyrinogen carboxy-lyase (EC 4.1.1.37). [HMDB] Heptacarboxylporphyrin I is a bile product that arises from the conversion of Heptacarboxylporphyrinogen I to Heptacarboxylporphyrin I by porphyrinogen carboxy-lyase (EC 4.1.1.37).
Pseudouroporphyrin
Porphyrins excreted in various types of porphyria (PubMed ID 5917679 ). Intermediate of haem biosynthesis (PubMed ID 1216185). Porphyrins excreted in various types of porphyria (PubMed ID 5917679 ).
Echinacoside
Heptacarboxylic porphyrin
Isorhamnetin 3-sophoroside 7-rhamnoside
Isolated from Hippophae rhamnoides [CCD]. Isorhamnetin 3-sophoroside 7-rhamnoside is found in sea-buckthornberry.
auriculatin 4′-O-glucoside
Echinacoside
Echinacoside is an oligosaccharide. Echinacoside is a phenylethanoid glycoside isolated from Echinacea angustifolia in 1950, and currently being investigated for the treatment of Parkinsons, Alzheimers, atherosclerosis, osteoporosis, acute colitis, wound treatment, and hepatitis. Echinacoside has demonstrated inhibition of apoptosis in neural cell lines, demonstrating potential for use in the treatment of neurological conditions. Echinacoside is a natural product found in Jasminum mesnyi, Pedicularis plicata, and other organisms with data available. Echinacoside, one of the phenylethanoids isolated from the stems of Cistanche deserticola, effectively inhibits Wnt/β-catenin signaling. Echinacoside elicits neuroprotection by activating Trk receptors and their downstream signal pathways. Antiosteoporotic activity[1][2][3]. Echinacoside, one of the phenylethanoids isolated from the stems of Cistanche deserticola, effectively inhibits Wnt/β-catenin signaling. Echinacoside elicits neuroprotection by activating Trk receptors and their downstream signal pathways. Antiosteoporotic activity[1][2][3].
Isorhamnetin 3-rhamnoside-7-sophoroside
Isorhamnetin 3-sophoroside-7-rhamnoside
6)-glucoside]
Luteolin 3-methyl ether 7-sophorotrioside
6)-galactoside
2)-galactoside-7-glucoside
Swertiajaponin 3-O-gentiobioside
Isorhamnetin 3-rutinoside-7-glucoside
Sexangularetin 3-rutinoside-7-glucoside
Isorhamnetin 3-rutinoside-4-glucoside
Calotropiside
Isorhamnetin 3-glucosyl- (1->2) - [ rhamnosyl- (1->6) -galactoside ]
5,10-Methenyltetrahydromethanopterin; 5,10-Methenyl-5,6,7,8-tetrahydromethanopterin; N5,N10-Methenyltetrahydromethanopterin
C31H43N6O16P (786.2473047999999)
moromycin A
An angucycline antibiotic that consists of a tetrangomycin skeleton linked to deoxy sugars through C-glycosidic and O-glycosidic bonds at positions 9 and 3 respectively. It is isolated from Streptomyces sp.KY002 and exhibits cytotoxicity against human lung cancer and MCF-7 human breast cancer cells.
Isorhamnetin 3-rhamnosyl-(1->2)-[glucosyl-(1->6)-glucoside]
Cassiaflavan-(4beta->8)-epiafzelechin-(4beta->8)-epiafzelechin
(3,4-Dihydroxy-phenaethyl)-[O2-(3,4-dihydroxy-trans-cinnamoyl)-O6-xi-D-glucopyranosyl-O4-xi-L-rhamnopyranosyl-xi-D-glucopyranosid]|(3,4-dihydroxy-phenethyl)-[O2-(3,4-dihydroxy-trans-cinnamoyl)-O6-xi-D-glucopyranosyl-O4-xi-L-rhamnopyranosyl-xi-D-glucopyranoside]
5-O-methylmyricetin 3-O-alpha-rhamnosyl-(1->2)-alpha-rhamnoside-3-O-beta-galactoside
2-(3,4-dihydroxyphenyl)ethyl 3-O-beta-D-glucopyranosyl-6-O-[(2E)-3-(4-hydroxyphenyl)-1-oxoprop-2-en-1-yl]-beta-D-glucopyranoside 4-[(2E)-3-(3,4-dihydroxyphenyl)prop-2-enoate]|2-(3,4-dihydroxyphenyl)ethyl O-6-O-(E)-p-coumaroyl-beta-D-glucopyranosyl-(1->3)-4-O-(E)-caffeoyl-beta-D-glucopyranoside|digilanatoside B
isorhamnetin 3-O-beta-D-glucopyranosyl-(1?3)-alpha-L-rhamnopyranosyl-(1?6)-beta-D-galactopyranoside
1-(2,3,4-trihydroxyphenyl) ethyl-3-O-rhamnose-4-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]-6-[(2E)-3-(3,4-dihydroxyphenyl)-2-propenoate]-glucopyranoside
(4-hydroxy-3-methoxyphenyl)-ethxoyl2-O-[5-O-[(2E)-3-[(2S,3R)-2,3-dihydro-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-7-methoxy-5-benzofuranyl]-1-oxo-2-propenyl]-beta-D-apiofuranosyl]-beta-D-glucopyranoside|bunginoside A
3,5-dimethoxymyricetin-3-O-beta-D-xylopyranosyl-7-O-fucopyranosyl-(1?3)-beta-D-glucopyranoside
Isorhamnetin 3-galactosyl-(1->4)-rhamnosyl-(1->6)-galactoside
Neoacteosid; 3,4-Dihydroxy-beta-phenylethyl-O-alpha-L-rhamnopyranosyl(1->3)-O-(beta-D-glucopyranosyl(1->6))-beta-D-(2-O-kaffoyl)-glucopyranosid|Neoacteosid; 3,4-Dihydroxy-beta-phenylethyl-O-alpha-L-rhamnopyranosyl(1->3)-O-[beta-D-glucopyranosyl(1->6)]-beta-D-(2-O-kaffoyl)-glucopyranosid
Isorhamnetin-(6-beta-D-glucopyranosyl-beta-D-glucofuranosid)-7-alpha-L-rhamnofuranosid|Isorhamnetin-<6-beta-D-glucopyranosyl-beta-D-glucofuranosid>-7-alpha-L-rhamnofuranosid
Isorhamnetin 3-rhamnosyl-(1->2)-galactoside-7-glucoside
isorhamnetin 3-O-(2-O-beta-glucopyranosyl)-beta-galactopyranoside-7-O-beta-glucopyranoside
3-O-Rhamnosylrutinoside-3,4,5,5,7-Pentahydroxy-3-methoxyflavone
3-O-[beta-D-Glucopyranosyl-(1?2)-[alpha-L-rhamnopyranosyl-(1?6)]-beta-D-galactopyranoside] 鈥樎?,4,5,7-Tetrahydroxy-3-methoxyflavone
Isorhamnetin3-sophoroside-7-rhamnoside
[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
[(2R,3R,4R,5R,6R)-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]-4-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
[4-[4,5-dihydroxy-6-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
methoxy-myricetin-3-O-hexosyl-7-O-deoxyhexosyl-deoxyhexoside
methoxy-myricetin-3-O-hexosyl-7-O-deoxyhexosyl(1-2)deoxyhexoside
[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
[4-[4,5-dihydroxy-6-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate [IIN-based: Match]
[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate_minor
[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate_major
[4-[4,5-dihydroxy-6-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate_major
[4-[4,5-dihydroxy-6-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate_minor
[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate_72.1\\%
[(2R,3R,4R,5R,6R)-4-[(2S,3R,4R,5R,6S)-4,5-dihydroxy-6-methyl-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-5-hydroxy-2-(hydroxymethyl)oxan-3-yl] (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate_84.9\\%
[4-[4,5-dihydroxy-6-methyl-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-6-[2-(3,4-dihydroxyphenyl)ethoxy]-3,5-dihydroxyoxan-2-yl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate_2.2\\%
Isorhamnetin 3-(4Rha-galactosylrobinobioside)
Isorhamnetin 3-glucosyl-(1->2)-[rhamnosyl-(1->6)-galactoside]
Isorhamnetin 3-(2G-galactosylrutinoside)
5,10-Methenyltetrahydromethanopterin
C31H43N6O16P (786.2473047999999)
Isorhamnetin 3-O-[b-D-glucopyranosyl-(1->2)-[a-L-rhamnopyranosyl-(1->6)]-b-D-glucopyranoside]
6,6-[(3,3-Di-t-butyl-5,5-dimethoxy-1,1-biphenyl-2,2-diyl)bis(oxy)]bis(dibenzo[d,f][1,3,2]dioxaphosphepin)hemiethylacetateadduct,min.95BIPHEPHOS
C46H44O8P2 (786.2511284000001)
Aldoxorubicin hydrochloride
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent
(1R,4R,7R,9R,10R,13R,15S)-7-[(2S,3R,4R,5S,6S)-6-(hydroperoxymethyl)-3-(3-methylbutanoyloxy)-4,5-disulfooxyoxan-2-yl]oxy-15-hydroxy-9-methyl-14-methylidenetetracyclo[11.2.1.01,10.04,9]hexadecane-5,5-dicarboxylic acid
C31H46O19S2 (786.2074606000001)
16,17-Dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene;sulfate;hydrate
C40H38N2O13S (786.2094498000001)
5,10-Methylene-tetrahydromethanopterin (iminium form)
C31H43N6O16P-2 (786.2473047999999)